Laekna, Inc. (HKG:2105)
Hong Kong · Delayed Price · Currency is HKD 11.67
-0.74 (-5.96%)
Last updated: May 28, 2026, 10:48 AM HKT
Laekna Market Cap
Laekna has a market cap or net worth of 5.22 billion as of May 27, 2026. Its market cap has decreased by -2.99% in one year.
Market Cap
5.22B
Enterprise Value
3.95B
Revenue
118.76M
Ranking
n/a
PE Ratio
n/a
Stock Price
11.67
Market Cap Chart
Since June 29, 2023, Laekna's market cap has decreased from 5.85B to 5.22B, a decrease of -10.81%. That is a compound annual growth rate of -3.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 27, 2026 | 5.22B | -8.04% |
| Dec 31, 2025 | 5.68B | 62.12% |
| Dec 31, 2024 | 3.50B | -54.90% |
| Dec 29, 2023 | 7.76B | 32.67% |
| Jun 29, 2023 | 5.85B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shanghai Haohai Biological Technology | 8.35B |
| Lepu Biopharma | 8.26B |
| Shanghai Bao Pharmaceuticals | 7.99B |
| Abbisko Cayman | 7.34B |
| CK Life Sciences Int'l., (Holdings) | 6.82B |
| Guangzhou Innogen Pharmaceutical Group | 5.55B |
| Ocumension Therapeutics | 5.09B |
| PegBio | 5.06B |